Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Xu, Yu  [Clear All Filters]
2021
Lu J, Cao L-L, Xu Y, Huang X-Y, Cho S-J, Ashktorab H, Smoot DT, Li P, Zheng C-H, Kim J-W, et al. FOXC1 modulates stem-like cell properties and chemoresistance through Hedgehog and EMT signaling in gastric adenocarcinoma. Mol Ther. 2021.
2022
Chen F, Xu Y, Shi K, Zhang Z, Xie Z, Wu H, Ma Y, Zhou Y, Chen C, Yang J, et al. Multi-omics study reveals associations among neurotransmitter, extracellular vesicle-derived microRNA and psychiatric comorbidities during heroin and methamphetamine withdrawal. Biomed Pharmacother. 2022;155:113685.
2023
Chen G, Lai S, Bao G, Ke J, Meng X, Lu S, Wu X, Xu H, Wu F, Xu Y, et al. Distinct reward processing by subregions of the nucleus accumbens. Cell Rep. 2023;42(2):112069.
Liao J, Wang J, Xu Y, Wu Y, Wang M, Zhao Q, Tan X, Meng Y, Wei L, Huang A. LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma. iScience. 2023;26(6):106754.
2024
Han S, Xu Y, Chen D, Yang F, Wang M, Zhou Q, Wang G, Li L, Xu C, Wang W, et al. Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors. iScience. 2024;27(1):108290.
Chen X, Yin Y, He Y, Meng F, Zhao J, Liu F, Xu Y, Wang G, Zhu X, Ma S, et al. The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer. Heliyon. 2024;10(3):e24858.